Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feriel Azibani

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Iscience|March 18, 2026
Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stressNoma Assad, Hugo Nordin, Alexis Nguyen, et al.
Intensive Care Medicine Experimental|June 7, 2024
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injuryBruno Garcia, Benoit Ter Schiphorst, Karine Santos, et al.
Eclinicalmedicine|January 13, 2025
Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trialsSabri Soussi, Tuukka Tarvasmäki, Antoine Kimmoun, et al.
Critical Care (London, England)|March 3, 2026
Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trialAdrien Picod, Jeremy Boussier, Sarah Tubiana, et al.
Critical Care (London, England)|May 20, 2025
Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO studyKhalil Chaïbi, Adrien Picod, Marouane Boubaya, et al.
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Iscience|March 18, 2026
Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stressNoma Assad, Hugo Nordin, Alexis Nguyen, et al.
Intensive Care Medicine Experimental|June 7, 2024
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injuryBruno Garcia, Benoit Ter Schiphorst, Karine Santos, et al.
Eclinicalmedicine|January 13, 2025
Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trialsSabri Soussi, Tuukka Tarvasmäki, Antoine Kimmoun, et al.
Critical Care (London, England)|March 3, 2026
Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trialAdrien Picod, Jeremy Boussier, Sarah Tubiana, et al.
Critical Care (London, England)|May 20, 2025
Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO studyKhalil Chaïbi, Adrien Picod, Marouane Boubaya, et al.
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
Pageof 6